METHODS OF MICROBIAL PRODUCTION OF EXCRETED PRODUCTS FROM METHANE AND RELATED BACTERIAL STRAINS

• US 20160237398A1
• Filed: 10/20/2014
• Published: 08/18/2016
• Est. Priority Date: 10/18/2013
• Status: Abandoned Application

• Current Assignee: University of Washington
• Original Assignee: University of Washington
• Inventors: Kalyuzhnaya, Marina, Lidstrom, Mary E.
• Application Number:
  US15/029,968
• Publication Number:
  US 20160237398A1
• Time in Patent Office: Days
• US Class Current: 1/1
• CPC Class Codes: C12N 1/20 Bacteria; Culture media therefor
• CPC Class Codes: C12N 9/0006 acting on CH-OH groups as donors (1.1)
• CPC Class Codes: C12N 9/1217 Phosphotransferases with a carboxyl group as acceptor (2.7.2)
• CPC Class Codes: C12P 3/00 Preparation of elements or inorganic compounds except carbon dioxide recovery of carbon dioxides as by-products C12F3/02
• CPC Class Codes: C12P 7/02 containing a hydroxy group
• CPC Class Codes: C12P 7/04 acyclic
• CPC Class Codes: C12P 7/40 containing a carboxyl group including Peroxycarboxylic acids
• CPC Class Codes: C12P 7/46 Dicarboxylic acids having four or less carbon atoms, e.g. fumaric acid, maleic acid
• CPC Class Codes: C12P 7/54 Acetic acid vinegar C12J
• CPC Class Codes: C12P 7/56 Lactic acid

Abstract

The present disclosure is directed to methods of producing excreted products through the fermentation of methane with methanotrophs. In certain embodiments, the methods are performed at low oxygen levels.

Claims

1. A method for producing at least one excreted product by microbial fermentation of a gaseous substrate, comprising:

a. providing a gaseous substrate comprising CH₄ and optionally, O₂, to a culture of at least one methanotrophic microorganism; and

b. maintaining the microorganism under conditions suitable for fermentation at a dissolved O₂ tension of between 0 and about 1% of saturation with air to produce at least one excreted product;

or

maintaining the microorganism under conditions suitable for fermentation at a dissolved O₂ tension of between 0 and about 40% of saturation with air and reducing respiration to produce at least one excreted product.

2. The method of claim 1, wherein the methanotrophic microorganism is a native methanotrophic microorganism.

3. The method of claim 1, wherein reducing respiration comprises contacting the microorganism with an inhibitor of the electron transport chain.

4. The method of claim 3, wherein the inhibitor is antimycin A.

15. The method of claim 1, wherein fermentation comprises:

a. converting the gaseous substrate to intracellular formaldehyde; and

b. converting the intracellular formaldehyde to at least one excreted product.

16. The method of claim 15, wherein fermentation further comprises reducing respiratory activity.

17. The method of claim 16, wherein respiratory activity is reduced by contacting the cell with a respiratory activity inhibitor or engineering the cell.

18. The method of claim 1, wherein fermentation comprises the conversion of formaldehyde to at least one excreted product by a metabolic pathway in which energy is generated by substrate-level phosphorylation.

19. The method of claim 1, further comprising separating the at least one excreted product from a liquid nutrient media.

20. The method of claim 1, wherein the culture of at least one methanotrophic microorganism is of a genus selected from the group consisting of Methylococcus, Methylomonas, Methylomicrobium, Methylobacter, Methylomarinum, Methylovulum, Methylocaldum, Methylothermus, Methylomarinovum, Methylosphaera, Methylocystis and Methylosinus, and a mixture thereof.

21. The method of claim 1, wherein the culture of at least one methanotrophic microorganism is selected from the group consisting of:

Methylomicrobium alcaliphilum;

Methylomicrobium buryatense;

Methylomonas spp; and

a mixture thereof.

22. The method of claim 19, wherein the culture and liquid medium are contained in a bioreactor.

23. The method of claim 19, wherein the culture and liquid medium are contained in a closed vial.

24. The method of claim 1, wherein the ratio of CH₄:

O₂ in the gaseous substrate is from about 10;

1 to about 1;

1

25. The method of claim 24, wherein the ratio of CH₄:

O₂ in the gaseous substrate is selected from the group consisting of;

about 10;

1;

about 5;

1;

about 4;

1;

about 2;

1;

about 1.5;

1 and about 1;

1.

26. The method of claim 1, wherein the at least one excreted product is an organic acid.

27. The method of claim 1, wherein the at least one excreted product is an alcohol.

28. The method of claim 26, wherein the organic acid is selected from the group consisting of:

succinate;

acetate;

butyrate;

lactate;

malate;

fumarate;

citrate;

glycerate;

formic acid;

stearic acid;

3-hydroxybutyrate;

propionate; and

mixtures thereof.

29. The method of claim 27, wherein the alcohol is selected from the group consisting of propanol, isopropanol, ethanol, or mixtures thereof.

5. A method for producing at least one excreted product by microbial fermentation of a gaseous substrate, comprising:

a. providing a gaseous substrate comprising CH₄ and optionally, O₂, to a culture of at least one methanotrophic microorganism; and

b. maintaining the microorganism under conditions suitable for fermentation to produce at least one excreted product.

6. The method of claim 5, wherein the methanotrophic microorganism is engineered to comprise a downregulated level of a gene selected from the group consisting of:

NAD-reducing hydrogenase (MALCv4_1304 and

     1307);

acetate kinase (MALCv4_2853);

lactate dehydrogenase (MALCv4_0534);

acetate kinase (MALCv4_2853) and lactate dehydrogenase (MALCv4_0534);

bacteriohemerythrin (MALCv4_2316);

sucrose-phosphate synthase (MALCv4_0614); and

sucrose-phosphate synthase (MALCv4_0614) and bactenohemerythnn (MALCv4_2316);

a member of the cytochrome bc1 complex (MALCv4_0634, MALCv4_0633, and MALCv4_0632);

a glycogen biosynthesis gene (MALCv4_3502;

MALCv4_3503;

MALCv_3504;

MALCv4_3505;

MALCv_3506;

MALCv4_3507, and MALCv_3508); and

cytochrome aa3 oxidase (MALCv4_2315).

7. The method of claim 6, wherein the methanotrophic microorganism is engineered to comprise a mutation selected from the group consisting of:

a deletion of NAD-reducing hydrogenase (MALCv4_1304 and

     1307);

a deletion of acetate kinase (MALCv4_2853);

a deletion of lactate dehydrogenase (MALCv4_0534);

a deletion of acetate kinase (MALCv4_2853) and lactate dehydrogenase (MALCv4_0534);

a deletion of bacteriohemerythrin (MALCv4_2316); and

a deletion of sucrose-phosphate synthase (MALCv4_0614);

a deletion of sucrose-phosphate synthase (MALCv4_0614) and bacteriohemerythrin (MALCv4_2316);

a deletion of a member of the cytochrome bc1 complex (MALCv4_0634, MALCv4_0633, and MALCv4_0632);

a deletion of a glycogen biosynthesis gene (MALCv4_3502;

MALCv4_3503;

MALCv_3504;

MALCv4_3505;

MALCv_3506;

MALCv4_3507, and MALCv_3508); and

deletion of cytochrome aa3 oxidase (MALCv4_2315).

8. The method of claim 5, wherein the method further comprises reducing respiration.

9. The method of claim 8, wherein reducing respiration comprises contacting the microorganism with an inhibitor of the electron transport chain.

10. The method of claim 9, wherein the inhibitor is antimycin A.

11. The method of claim 5, wherein the microorganism is maintained under conditions suitable for fermentation at a dissolved O₂ tension of between 0 and about 40% of saturation with air to produce at least one excreted product.

12. The method of claim 5, wherein the dissolved O₂ tension is between 0 and about 10%.

13. The method of claim 12, wherein the dissolved O₂ tension is between 0 and about 1%.

14. The method of claim 13, wherein the dissolved O₂ tension is between 0 and about 0.1%.

30. An engineered methanotrophic bacterium capable of fermenting methane comprising a deletion of one or more of the following genes:

a. NADH-ubiquinone oxidoreductase (MALCv4_1304);

b. hydrogenase (MALCv4_1307);

c. acetate kinase (MALCv4_2853); and

d. lactate dehydrogenase (MALCv4_0534);

e. NAD-reducing hydrogenase (MALCv4_1304 and

     1307);

f. bacteriohemelythrin (MALCv4_2316);

g. sucrose-phosphate synthase (MALCv4_0614);

h. a member of the cytochrome bc1 complex (MALCv4_0634, MALCv4_0633, and MALCv4_0632);

i. a glycogen biosynthesis gene (MALCv4_3502;

MALCv4_3503;

MALCv_3504;

MALCv4_3505;

MALCv_3506;

MALCv4_3507, and MALCv_3508); and

j. cytochrome aa3 oxidase (MALCv4_2315).

31. The engineered methanotrophic bacterium of claim 30, wherein the engineered methanotrophic bacterium is selected from the genus consisting of Methylococcus, Methylomonas, Methylomicrobium, Methylobacter, Methylothermus, Methylocaldum, Methylosphaera, Methylocystis, Methylomarinovum, Methylomicrobium alcaliphilum, Methylomicrobium buryatense and Methylosinus.